1
TITLE: Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley J Monk; Helen MacKay; Alessandro D Santin; David Scott Miller ; Richard G Moore; Sally Baron Hay; Isabelle Ray Coquard; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva M Guerra Alia; Ulus A Sanli; Steven Bird; Robert Orlowski; Jodi McKenzie; Chinyere Okpara; Gianmaria Barresi; Domenica Lorusso; ...More
PUBLISHED: 2023, SOURCE: Journal of Clinical Oncology, VOLUME: 41, ISSUE: 16
INDEXED IN: Scopus CrossRef: 16
2
TITLE: Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice  Full Text
AUTHORS: Domenica Lorusso; Nicoletta Colombo; Antonio Casado Herraez; Alessandro D Santin; Emeline Colomba; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Sally E Baron Hay; Isabelle Laure Ray Coquard; Ronnie Shapira Frommer; Yong Man Kim; Mary McCormack; Rachid Massaad; Allison Martin Nguyen; Qi Zhao; Jodi McKenzie; Vimalanand S Prabhu; Vicky Makker;
PUBLISHED: 2023, SOURCE: European Journal of Cancer, VOLUME: 186
INDEXED IN: Scopus CrossRef: 2
3
TITLE: O018/#482 Updated safety of lenvatinib + pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley Monk; Helen Mackay; Alessandro Santin; David Scott Miller ; Richard Moore; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva Guerra Alia; Ulus Sanli; Ran Xie; Melissa Zale; Jodi Mckenzie; Gianmaria Barresi; Domenica Lorusso;
PUBLISHED: 2022, SOURCE: Focused Plenary Abstracts
INDEXED IN: CrossRef